Toolkit/CBN-loaded soy lecithin liposomes

CBN-loaded soy lecithin liposomes

Construct Pattern·Research·Since 2025

Also known as: CBN-loaded liposomes, soy lecithin liposomes

Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

Based on these findings, CBN was selected for formulation into soy lecithin liposomes. The resulting CBN-loaded liposomes displayed favorable colloidal properties, with an average size of approximately 122.9 ± 0.4 nm.

Usefulness & Problems

Why this is useful

This formulation encapsulates cannabinol in soy lecithin liposomes and is presented as an antioxidant delivery system with enhanced diffusion behavior. The abstract reports favorable colloidal properties, increased membrane order, and retained radical scavenging activity.; encapsulation of cannabinol for antioxidant delivery; early-stage dermal formulation development; enhancing diffusion behavior in a semi-solid model

Source:

This formulation encapsulates cannabinol in soy lecithin liposomes and is presented as an antioxidant delivery system with enhanced diffusion behavior. The abstract reports favorable colloidal properties, increased membrane order, and retained radical scavenging activity.

Source:

encapsulation of cannabinol for antioxidant delivery

Source:

early-stage dermal formulation development

Source:

enhancing diffusion behavior in a semi-solid model

Problem solved

It addresses delivery of an antioxidant cannabinoid in a liposomal format while improving diffusion in an early-stage semi-solid model. The paper frames it as promising for dermal antioxidant applications.; provides a liposomal delivery format for CBN; improves diffusion relative to a control solution in the reported model

Source:

It addresses delivery of an antioxidant cannabinoid in a liposomal format while improving diffusion in an early-stage semi-solid model. The paper frames it as promising for dermal antioxidant applications.

Source:

provides a liposomal delivery format for CBN

Source:

improves diffusion relative to a control solution in the reported model

Problem links

improves diffusion relative to a control solution in the reported model

Literature

It addresses delivery of an antioxidant cannabinoid in a liposomal format while improving diffusion in an early-stage semi-solid model. The paper frames it as promising for dermal antioxidant applications.

Source:

It addresses delivery of an antioxidant cannabinoid in a liposomal format while improving diffusion in an early-stage semi-solid model. The paper frames it as promising for dermal antioxidant applications.

provides a liposomal delivery format for CBN

Literature

It addresses delivery of an antioxidant cannabinoid in a liposomal format while improving diffusion in an early-stage semi-solid model. The paper frames it as promising for dermal antioxidant applications.

Source:

It addresses delivery of an antioxidant cannabinoid in a liposomal format while improving diffusion in an early-stage semi-solid model. The paper frames it as promising for dermal antioxidant applications.

Published Workflows

Objective: Identify a cannabinoid with strong antioxidant performance and convert it into a liposomal formulation with favorable physicochemical properties and improved diffusion behavior for dermal antioxidant applications.

Why it works: The workflow first profiles structurally distinct cannabinoids to identify the strongest antioxidant candidate, then formulates the selected compound into liposomes and tests whether key delivery-relevant properties and diffusion behavior are preserved or improved.

radical scavengingincreased membrane order associated with liposomal bilayer stabilityMS structural characterizationNMR structural characterizationliposomal encapsulationantioxidant activity assaysEPR imaging

Stages

  1. 1.
    Analytical profiling of structurally distinct cannabinoids(broad_screen)

    This stage identifies which cannabinoid is the strongest antioxidant candidate before committing to formulation work.

    Selection: Structural characterization and antioxidant profiling across DPPH, hydroxyl, and superoxide radical scavenging assays.

  2. 2.
    Liposomal formulation of the selected cannabinoid(library_build)

    This stage converts the selected antioxidant cannabinoid into a delivery format suitable for downstream physicochemical and diffusion testing.

    Selection: Formulate the selected antioxidant payload into soy lecithin liposomes.

  3. 3.
    Physicochemical and functional characterization of CBN-loaded liposomes(secondary_characterization)

    This stage checks whether the liposomal formulation remains physically suitable and functionally active after loading CBN.

    Selection: Assess colloidal properties, membrane order, and retained antioxidant activity after encapsulation.

  4. 4.
    Diffusion testing in a gelatin-based semi-solid model(confirmatory_validation)

    This stage provides an early-stage screen of whether the formulation improves mobility in a model relevant to dermal application goals.

    Selection: Use EPR imaging to compare diffusion of liposomal CBN against a control solution in a semi-solid model.

  5. 5.
    Decision framing for dermal antioxidant application(decision_gate)

    This stage interprets whether the combined data justify positioning the formulation as a promising dermal antioxidant candidate.

    Selection: Integrate physicochemical, antioxidant, and diffusion results to assess promise for dermal antioxidant use.

Steps

  1. 1.
    Characterize five cannabinoids by MS and NMR

    Identify structural features relevant to antioxidant function before selecting a formulation payload.

    Structural characterization precedes candidate selection because the study first profiles the tested cannabinoids before choosing one for formulation.

  2. 2.
    Measure radical scavenging across DPPH, hydroxyl, and superoxide assays and select CBN

    Rank antioxidant performance and choose the lead cannabinoid for formulation.

    Selection occurs after profiling because the formulation stage is explicitly based on these antioxidant findings.

  3. 3.
    Formulate selected CBN into soy lecithin liposomesengineered formulation

    Create a delivery system for the selected antioxidant cannabinoid.

    Formulation follows lead selection because only the top antioxidant candidate was advanced into liposomes.

  4. 4.
    Measure colloidal size and membrane order of CBN-loaded liposomesformulation under characterization

    Assess whether the liposomal formulation has favorable colloidal properties and signs of bilayer stabilization.

    Physicochemical characterization is performed after formulation to determine whether the assembled liposomes are suitable for downstream functional testing.

  5. 5.
    Test retained antioxidant activity of CBN-loaded liposomes against free CBNformulation under functional comparison

    Determine whether encapsulation preserves radical scavenging function.

    Functional antioxidant testing follows formulation because the key question is whether encapsulation retains activity relative to the free compound.

  6. 6.
    Compare diffusion of liposomal CBN and control solution by EPR imaging in a gelatin semi-solid modelformulation and assay platform

    Evaluate whether the liposomal formulation improves mobility in an early-stage dermal-relevant model.

    Diffusion testing is done after physicochemical and antioxidant characterization to assess whether a functionally acceptable formulation also shows improved mobility.

  7. 7.
    Interpret early-stage diffusion model results with explicit model limitationcandidate formulation and screening model

    Decide whether the combined evidence is sufficient to position the formulation as promising for dermal antioxidant use.

    This interpretation follows all characterization and diffusion testing so the application claim can be made with stated caveats.

Taxonomy & Function

Primary hierarchy

Mechanism Branch

Architecture: A reusable architecture pattern for arranging parts into an engineered system.

Target processes

recombination

Input: Chemical

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: regulator

The reported system requires cannabinol, soy lecithin liposome formulation, antioxidant activity assays, and EPR imaging in a gelatin-based semi-solid model for the described evaluation workflow.; requires formulation of CBN into soy lecithin liposomes; performance evidence is limited in the abstract to physicochemical assays, radical scavenging assays, and a gelatin-based semi-solid diffusion model

The abstract does not show performance in actual skin architecture or in vivo dermal delivery. It also notes a moderate reduction in antioxidant activity relative to free CBN after encapsulation.; moderate reduction in antioxidant activity compared to free CBN; reported diffusion model does not replicate skin architecture

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1activity retentionmixed2025Source 1needs review

CBN-loaded liposomes retained significant radical scavenging activity, but this activity was moderately reduced compared with free CBN.

Antioxidant activity assays showed that CBN-loaded liposomes retain significant radical scavenging capacity, though with a moderate reduction compared to free CBN.
Claim 2application potentialsupports2025Source 1needs review

CBN-loaded liposomes are presented as a promising candidate for dermal antioxidant applications because they combine favorable physicochemical properties with enhanced diffusion behavior.

These results position CBN-loaded liposomes as a promising candidate for dermal antioxidant applications, combining favorable physicochemical properties with enhanced diffusion behavior.
Claim 3assay scope limitationmixed2025Source 1needs review

The gelatin-based semi-solid EPR diffusion model is cost-effective and reproducible for early-stage mobility screening but does not replicate skin architecture.

While the current model does not replicate skin architecture, it provides a cost-effective and reproducible platform for early-stage screening of formulation mobility.
Claim 4diffusion performancesupports2025Source 1needs review

In a gelatin-based semi-solid model, liposomal CBN showed superior diffusion compared with the control solution by EPR imaging.

EPR imaging further demonstrated superior diffusion of liposomal CBN through a gelatin-based semi-solid model compared to the control solution.
Claim 5mechanistic inferencesupports2025Source 1needs review

Increased membrane order after CBN incorporation suggests enhanced stability of the liposomal bilayer.

Results indicating increased membrane order upon CBN incorporation suggest enhanced stability of the liposomal bilayer.
Claim 6physicochemical propertysupports2025Source 1needs review

CBN-loaded soy lecithin liposomes had favorable colloidal properties with an average size of about 122.9 ± 0.4 nm.

The resulting CBN-loaded liposomes displayed favorable colloidal properties, with an average size of approximately 122.9 ± 0.4 nm.
average particle size 122.9 nmparticle size variation 0.4 nm

Approval Evidence

1 source5 linked approval claimsfirst-pass slug cbn-loaded-soy-lecithin-liposomes
Based on these findings, CBN was selected for formulation into soy lecithin liposomes. The resulting CBN-loaded liposomes displayed favorable colloidal properties, with an average size of approximately 122.9 ± 0.4 nm.

Source:

activity retentionmixed

CBN-loaded liposomes retained significant radical scavenging activity, but this activity was moderately reduced compared with free CBN.

Antioxidant activity assays showed that CBN-loaded liposomes retain significant radical scavenging capacity, though with a moderate reduction compared to free CBN.

Source:

application potentialsupports

CBN-loaded liposomes are presented as a promising candidate for dermal antioxidant applications because they combine favorable physicochemical properties with enhanced diffusion behavior.

These results position CBN-loaded liposomes as a promising candidate for dermal antioxidant applications, combining favorable physicochemical properties with enhanced diffusion behavior.

Source:

diffusion performancesupports

In a gelatin-based semi-solid model, liposomal CBN showed superior diffusion compared with the control solution by EPR imaging.

EPR imaging further demonstrated superior diffusion of liposomal CBN through a gelatin-based semi-solid model compared to the control solution.

Source:

mechanistic inferencesupports

Increased membrane order after CBN incorporation suggests enhanced stability of the liposomal bilayer.

Results indicating increased membrane order upon CBN incorporation suggest enhanced stability of the liposomal bilayer.

Source:

physicochemical propertysupports

CBN-loaded soy lecithin liposomes had favorable colloidal properties with an average size of about 122.9 ± 0.4 nm.

The resulting CBN-loaded liposomes displayed favorable colloidal properties, with an average size of approximately 122.9 ± 0.4 nm.

Source:

Comparisons

Source-stated alternatives

The abstract contrasts the liposomal formulation with free CBN and a control solution in diffusion testing. It also compares CBN against four other structurally distinct cannabinoids during the initial antioxidant profiling stage.

Source:

The abstract contrasts the liposomal formulation with free CBN and a control solution in diffusion testing. It also compares CBN against four other structurally distinct cannabinoids during the initial antioxidant profiling stage.

Source-backed strengths

favorable colloidal properties; increased membrane order suggesting enhanced bilayer stability; retains significant radical scavenging capacity after encapsulation; superior diffusion through a gelatin-based semi-solid model versus control solution

Source:

favorable colloidal properties

Source:

increased membrane order suggesting enhanced bilayer stability

Source:

retains significant radical scavenging capacity after encapsulation

Source:

superior diffusion through a gelatin-based semi-solid model versus control solution

Compared with cdiGEBS

CBN-loaded soy lecithin liposomes and cdiGEBS address a similar problem space because they share recombination.

Shared frame: same top-level item type; shared target processes: recombination; same primary input modality: chemical

Compared with H-2Kb-ADSCs

CBN-loaded soy lecithin liposomes and H-2Kb-ADSCs address a similar problem space because they share recombination.

Shared frame: same top-level item type; shared target processes: recombination; same primary input modality: chemical

CBN-loaded soy lecithin liposomes and orthoflavivirus pseudovirus technology address a similar problem space because they share recombination.

Shared frame: same top-level item type; shared target processes: recombination; same primary input modality: chemical

Ranked Citations

  1. 1.

    Extracted from this source document.